Researchers at Noramco study analytical methods to detect and determine the presence of potentially genotoxic impurities (PGIs) in pharmaceutical products.
Noramco to attend AAPS
Why is Noramco leveraging expertise in APIs to provide solutions to stability, bioavailability, and purity challenges?
Noramco to attend CPhI in Frankfurt Germany
Meet us at CPhI Worldwide for more information about “one-stop API development and manufacturing.”